Drugs
Psychedelics can change how you think about the universe
A new study finds that a single trip on a psychedelic can cause lasting changes in a person's metaphysical beliefs.
Psilocybin treatment relieves depression in largest trial yet
The largest psilocybin treatment trial to date suggests that the psychedelic drug can help people with treatment-resistant depression.
Rhode Island will be the first state to open safe drug consumption sites
In an important test of drug harm reduction techniques, Rhode Island is set to become the first state to open safe consumption sites.
Trial of opioid vaccine launches in US
An opioid vaccine that prevents people with opioid use disorder from feeling “high” when they take oxycodone is moving to human trials.
Yale study: magic mushrooms may grow connections between brain cells
A single dose of psilocybin caused increased growth in neuron-connecting dendritic spines in mice.
Series|
Just Might Work
Is DMT the best new treatment for depression?
Psychedelic therapy could bring the ancient healing powers of drugs like DMT into mental health clinics.
Pharma giant GSK embraces digital twins for vaccine development
Pharma leviathan GlaxoSmithKline is rolling out digital twins to help create “the vaccine factory of the future.”
Low doses of nitrous oxide may treat depression
A new, small study has found that low doses of nitrous oxide — laughing gas — can treat symptoms of depression.
A small dose of an ibogaine-like drug cures stress in mice
A novel drug designed like ibogaine but without the ibogaine trip or toxicity has corrected the effects of stress in mice.
Ketamine infusion: What it's like and how it works
Ketamine infusion therapy takes the anesthetic from dance floors to depression clinics. But how does the drug work, and what is it like?